Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 14;7(6):471-473.
doi: 10.1177/24741264231210064. eCollection 2023 Nov-Dec.

From the Editor-in-Chief

Editorial

From the Editor-in-Chief

Timothy G Murray. J Vitreoretin Dis. .
No abstract available

PubMed Disclaimer

Figures

None
Photo courtesy of Kevin Caldwell Photography.

References

    1. Sharma A, Loewenstein A, Parachuri N, Kumar N, Kuppermann BD. Biosimilar to biosimilar anti-VEGF switching for retinal diseases. J Vitreoretin Dis. 2023;7(6):474-476. - PMC - PubMed
    1. Shaheen A, Lai J, Magraner M, et al.. Clinical outcome of cystoid macular edema in silicone oil–filled eyes. J Vitreoretin Dis. 2023; 7(6):477-482. - PMC - PubMed
    1. Lam SS, Shahlaee A, Salabati M, Klufas MA. Clinical outcomes of retinal arterial macroaneurysms with vitreous hemorrhage treated with observation, antivascular endothelial growth factor intravitreal injections, or pars plana vitrectomy. J Vitreoretin Dis. 2023;7(6):483-489. - PMC - PubMed
    1. Sheth VS, Singer M, MacCumber M, et al.. Long-term control of retinal thickness variability and vision following the 0.19 mg fluocinolone acetonide implant. J Vitreoretin Dis. 2023;7(6): 490-497. - PMC - PubMed
    1. Russell MW, Chalasani M, Rana N, et al.. Effect of prefilled vs vial-drawn syringes on sustained increases in intraocular pressure in patients treated with aflibercept. J Vitreoretin Dis. 2023; 7(6):498-503. - PMC - PubMed

Publication types

LinkOut - more resources